A recent study demonstrated that the expression and activity of TLR-2 and TLR-4 are increased in monocytes from patients with MetS compared to patients without MetS, in turn, these receptors are activated and produce pro-inflammatory cytokines contribute to the increased risk of CHD [38]. Here, TLR2 is linked to metabolic syndrome.